Abstract
This cohort study examines the role of comprehensive bridging radiotherapy in the setting of chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have